EUVIMEDEUVIMED entdecken
Kohortenstudie

Growth differentiation factor-15 predicts all-cause death and major adverse cardiovascular events in patients with coronary heart disease: a prospective cohort study

Lyu Lyu, Cui Xv, Juan Xu, Zhenzhen Liu, Yanru He, Wenjing Zhu, Lin Lin, Qiang Yang, Yun Wei, Jinda Wang, Taoke Huang, Benchuan Hao und 1 weitere

Journal of Thrombosis and Thrombolysis · 2024

DOI: 10.1007/s11239-024-03019-5 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Thrombosis and Thrombolysis, 2024. Verfasst von Lyu Lyu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Second Medical Center, Chinese PLA General Hospital, Beijing, China. Hauptthemen laut MEDLINE: Growth Differentiation Factor 15, Coronary Disease. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The prognostic value of growth differentiation factor-15 (GDF-15) in predicting long-term adverse outcomes in coronary heart disease (CHD) patients remains limited. Our study examines the association between GDF-15 and adverse outcomes over an extended period in CHD patients and firstly assesses the incremental prognostic effect of incorporating GDF-15 into the Framingham risk score (FRS)-based model. This single-center prospective cohort study included 3,321 patients with CHD categorized into 2,479 acute coronary syndrome (ACS) (74.6%) and 842 non-ACS (25.4%) groups. The median age was 61.0 years (range: 53.0-70.0), and 917 (27.6%) were females. Mortality and major adverse cardiovascular events (MACEs) included cardiovascular mortality, myocardial infarction (MI), stroke, and heart failure (HF) (inclusive of HF episodes requiring outpatient treatment and/or hospital admission). Cox regression models assessed the associations between GDF-15 and the incidence of all-cause mortality and MACEs. Patients were stratified into three groups based on GDF-15 levels: the first tertile group ( 2,556 ng/L). The C-index, integrated discrimination improvement (IDI), net reclassification improvement (NRI), and decision curve analysis (DCA) were used to assess incremental value. Over a median 9.4-year follow-up, 759 patients (22.9%) died, and 1,291 (38.9%) experienced MACEs. The multivariate Cox model indicated that GDF-15 was significantly associated with all-cause mortality (per ln unit increase, HR = 1.49, 95% CI: 1.36-1.64) and MACEs (per ln unit increase, HR = 1.29, 95% CI: 1.20-1.38). These associations persisted when GDF-15 was analyzed as an ordinal variable (p for trend < 0.05). Subgroup analysis of ACS and non-ACS for the components of MACEs separately showed a significant association between GDF-15 and both cardiovascular mortality and HF, but no association was observed between GDF-15 and MI /stroke in both ACS and non-ACS patients. The addition of GDF-15 to the FRS-based model enhanced the discrimination for both all-cause mortality (∆ C-index = 0.009, 95% CI: 0.005-0.014; IDI = 0.030, 95% CI: 0.015-0.047; continuous NRI = 0.631, 95% CI: 0.569-0.652) and MACEs (∆ C-index = 0.009, 95% CI: 0.006-0.012; IDI = 0.026, 95% CI: 0.009-0.042; continuous NRI = 0.593, 95% CI: 0.478-0.682). DCA suggested that incorporating GDF-15 into the FRS-based model demonstrated higher net benefits compared to FRS-based models alone (All-cause mortality: FRS-based model: area under the curve of DCA (AUDC) = 0.0903, FRS-based model + GDF-15: AUDC = 0.0908; MACEs: FRS-based model: AUDC = 0.1806, FRS-based model + GDF-15: AUDC = 0.1833). GDF-15 significantly associates with the long-term prognosis of all-cause mortality and MACEs in CHD patients and significantly improves the prognostic accuracy of the FRS-based model for both outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Growth Differentiation Factor 15Coronary DiseaseHumansFemaleMiddle AgedMaleAgedProspective StudiesPrognosisAcute Coronary SyndromeHeart FailureMyocardial InfarctionBiomarkersCause of DeathPredictive Value of TestsStroke

Stichwörter der Autor:innen

All-cause mortalityCoronary heart diseaseFramingham risk scoreGrowth differentiation factor-15Major adverse cardiovascular events

Substanzen

Growth Differentiation Factor 15GDF15 protein, humanBiomarkers

Autor:innen und Institutionen

  • Department of Cardiology, The Second Medical Center, Chinese PLA General Hospital, Beijing, China.
  • Medical School of Chinese PLA, Beijing, China.
  • Department of Medical Administration, The 305 Hospital of PLA, Beijing, China.
  • Department of General Surgery, Affiliated Xiaoshan Hospital, Hangzhou Normal University, Hangzhou, China.
  • Department of Cardiology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Department of Cardiology, The Sixth Medical Center, Chinese PLA General Hospital, Beijing, China.

Zitieren

APA

Lyu, L., Xv, C., Xu, J., Liu, Z., He, Y., Zhu, W., Lin, L., Yang, Q., Wei, Y., Wang, J., Huang, T., Hao, B., & Liu, H. (2024). Growth differentiation factor-15 predicts all-cause death and major adverse cardiovascular events in patients with coronary heart disease: a prospective cohort study. Journal of Thrombosis and Thrombolysis. https://doi.org/10.1007/s11239-024-03019-5

Vancouver

Lyu L, Xv C, Xu J, Liu Z, He Y, Zhu W, et al. Growth differentiation factor-15 predicts all-cause death and major adverse cardiovascular events in patients with coronary heart disease: a prospective cohort study. Journal of Thrombosis and Thrombolysis. 2024. doi:10.1007/s11239-024-03019-5

BibTeX
@article{Lyu2024,
  author = {Lyu, Lyu and Xv, Cui and Xu, Juan and Liu, Zhenzhen and He, Yanru and Zhu, Wenjing and Lin, Lin and Yang, Qiang and Wei, Yun and Wang, Jinda and Huang, Taoke and Hao, Benchuan and Liu, Hongbin},
  title = {Growth differentiation factor-15 predicts all-cause death and major adverse cardiovascular events in patients with coronary heart disease: a prospective cohort study},
  journal = {Journal of Thrombosis and Thrombolysis},
  year = {2024},
  doi = {10.1007/s11239-024-03019-5}
}
Kostenlos starten →